Lipoprotein (a) and Hypertension

Research output: Contribution to journalReview articlepeer-review

13 Citations (Scopus)

Abstract

Purpose of Review: To provide an overview of the associations between elevated blood pressure and lipoprotein (a) and possible causal links, as well as data on the prevalence of elevated lipoprotein (a) in a cohort of hypertensive patients. Recent Findings: Elevated lipoprotein (a) is now considered to be an independent and causal risk factor for atherosclerotic cardiovascular disease and calcific aortic valve disease. Despite this, there are limited data demonstrating an association between elevated lipoprotein (a) and hypertension. Further, there is limited mechanistic data linking lipoprotein (a) and hypertension through either renal impairment or direct effects on the vasculature. Summary: Despite the links between lipoprotein (a) and atherosclerosis, there are limited data demonstrating an association with hypertension. Evidence from our clinic suggests that ~ 30% of the patients in this at-risk, hypertensive cohort had elevated lipoprotein (a) levels and that measurement of lipoprotein (a) maybe useful in risk stratification.

Original languageEnglish
Article number44
JournalCurrent Hypertension Reports
Volume23
Issue number12
DOIs
Publication statusPublished - Dec 2021

Fingerprint

Dive into the research topics of 'Lipoprotein (a) and Hypertension'. Together they form a unique fingerprint.

Cite this